Patent Assignment
Reel/Frame 015147/0743
Change of Address
Recorded: 2004-04-06
Pages: 4
Assignor
OSI PHARMACEUTICALS, INC.
Executed: 2002-04-10
Assignee
OSI PHARMACEUTICALS, INC.
58 SOUTH SERVICE ROAD, SUITE 110, MELVILLE, NEW YORK, 11747
Covered Properties
(38)
Monoclonal Antibodies Recognizing Parathyroid Hormone - Like Protein
Patent:
5,217,896 →
Application:
07/292,263 →
Monoclonal Antibodies Directed to Epitopes of Human Transforming Growth Factor - Alpha and Uses Thereof
Patent:
5,190,858 →
Application:
07/304,947 →
A Method for Obtaining Bone Marrow Free of Tumor Cells Using Transforming Growth Factor-B3
Patent:
5,262,319 →
Application:
07/543,341 →
Methods of Determining Chemicals That Modulate Expression of Genes Associated with Cardiovascular Disease
Patent:
5,580,722 →
Application:
07/832,905 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
5,824,297 →
Application:
08/115,519 →
Tissue-Derived Tumor Growth Inhibitors
Patent:
6,586,394 →
Application:
08/188,197 →
Methods of Preparing Compositions Comprising Chemicals Capable of Transcriptional Modulation
Patent:
6,203,976 →
Application:
08/255,236 →
Method of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,665,543 →
Application:
08/267,834 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
6,559,123 →
Application:
08/294,061 →
Methods of Prevention of Oral Mucositis with Transforming Growth Factor Beta
Patent:
5,817,625 →
Application:
08/370,227 →
Methods of Prevention of Oral Mucositis with Transforming Growth Factor Beta
Patent:
5,635,489 →
Application:
08/395,909 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
6,425,769 →
Application:
08/457,097 →
Methods of Transcriptionally Modulating Gene Expression
Patent:
5,776,502 →
Application:
08/458,691 →
Methods of Preparing Compositions Comprising Chemicals Capable of Transcriptional Modulation
Patent:
6,589,733 →
Application:
08/463,398 →
Methods of Transcriptionally Modulating Expression of Viral Genes and Genes Useful for Production of Proteins
Patent:
6,165,712 →
Application:
08/463,691 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
5,871,724 →
Application:
08/476,014 →
Methods of Transcriptionally Modulating Gene Expression and of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,976,793 →
Application:
08/683,455 →
Methods of Determining Chemicals That Modulate Expression of Genes Associated with Cardiovascular Disease
Patent:
5,846,720 →
Application:
08/700,757 →
Methods of Specifically Transcriptionally Modulating the Expression of a Gene of Interest
Patent:
6,136,779 →
Application:
08/778,754 →
Methods of Transcriptionally Modulating Gene Expression and of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,863,733 →
Application:
08/779,230 →
Synthesis and Use of Thiophene- and Pyrrole-Based Heteroaromatic Compounds
Patent:
6,037,340 →
Application:
08/864,240 →
Methods of Transcriptionally Modulating Gene Expression
Application:
09/047,966 →
Publication:
US 2003/0138773
Yetracyclic Compounds for Enhancing Biosynthesis of Erythropoietin, Compositions Containing Same, and Methods of Use Thereof
Patent:
5,985,913 →
Application:
09/069,693 →
Conformationally Constrained Peptidomimetics as Beta-Turn Templates and Modulators of SH3 Domains
Patent:
6,638,941 →
Application:
09/086,168 →
Methods of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
6,376,175 →
Application:
09/123,728 →
Solid Phase Synthesis of Heterocycles
Patent:
6,376,667 →
Application:
09/198,697 →
N-(3-Ethynylphenylamino)-6,7-Bis(2-Methoxyethoxy)-4-Quinazolinamine Mesylate Anhydrate and Monohydrate
Patent:
6,706,721 →
Application:
09/355,534 →
Preparation of Pyridone-Based Phosphotyrosine Mimetics and Uses Thereof
Patent:
6,465,495 →
Application:
09/363,877 →
Ags Proteins and Nucleic Acid Molecules and Uses Thereof
Patent:
6,746,852 →
Application:
09/439,410 →
Compounds Specific to Adenosine A1 Receptor and Uses Thereof
Patent:
6,878,716 →
Application:
09/454,074 →
Compounds Specific to Adenosine A3 Receptor and Uses Thereof
Patent:
6,686,366 →
Application:
09/454,075 →
Ags Proteins and Nucleic Acid Molecules and Uses Therefor
Patent:
6,733,991 →
Application:
09/709,103 →
Stable Polymorph on N-(3-Ethynylphenyl)-6, 7-Bis (2METHOXYETHOXY)-4-Quinazolinamine Hydrochloride, Methods of Production, and Phamaceutical Uses Thereof
Patent:
6,900,221 →
Application:
09/711,272 →
Pyrrolo [2, 3D] Pyrimidine Compositions and Their Use
Compounds Specific to Adenosine A1 Receptors and Uses Thereof
4-Aminopyrrolo [2,3-D] Pyrimidine Compounds Specific to Adensosine A2A Receptor and Uses Thereof
Compounds Specific to Adenosine A3 Receptor and Uses Thereof
N- (3-Ethynylphenyl) -6, 7-Bis (2-Methoxyethoxy) -4-Quinazolinamine Mesylate Anhydrate and Monohydrate
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Mar 14, 1989
From: VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H. JR; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 005041/0887 →
Assignment of Assignors Interest.
May 1, 1989
From: SORVILLO, JOHN M.; VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H. JR.
To: ONOCOGENE SCIENCE, INC., A CORP. OF DE
Reel/Frame 005067/0818 →
Assignment of Assignors Interest.
Nov 1, 1990
From: IWATA, KENNETH K.; FOULKES, J. GORDON; DIJKE, PETER T.; HALEY, JOHN D.
To: ONCOGENE SCIENCE, INC., A CORP. OF DE
Reel/Frame 005517/0430 →
Assignment of Assignors Interest.
May 4, 1992
From: FOULKES, J. GORDON; LIECHTFRIED, FRANZ E.; PIELER, CHRISTIAN; STEPHENSON, JOHN R.
To: ONCOGENE SCIENCE, INC., A DELAWARE CORPORATION
Reel/Frame 006107/0504 →
Assignment of Assignors Interest.
Dec 18, 1992
From: KRAMER, STEVEN P.; VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H., JR.; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006359/0846 →
Assignment of Assignor's Interest
Nov 3, 1993
From: IWATA, KENNETH K.; FOULKES, J. GORDON; DIJKE, PETER TEN; HALEY, JOHN D.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006748/0348 →
Assignment of Assignor's Interest
Apr 5, 1994
From: IWATA, KENNETH K.; STEPHENSON, JOHN R.; GOLD, LESLIE I.
To: ONCOGENE SCIENCE INC.
Reel/Frame 006934/0715 →
Assignment of Assignor's Interest
Dec 22, 1997
From: CASTELHANO, ARLINDO L.; MCKIBBEN, BRYAN
To: CADUS PHARMACEUTICAL CORPORATION
Reel/Frame 008866/0920 →
Assignment of Assignor's Interest
Jul 1, 1998
From: WILLIAMS, JONATHAN GARETH; HOUCK, DAVID R.; SMITH, DAVID EDWARD; RATHBONE, DANIEL LEE
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 009303/0457 →
See Recording at Reel 9636, Frame 0077. (Re-Record to Correct the Number of Microfilm Pages from 5 to 3)
Jul 23, 1998
From: CASTELHANO, ARLINDO; WITTER, DAVID J.
To: CADUS PHARMACEUTICAL CORPORATION
Reel/Frame 009574/0282 →
Assignment of Assignor's Interest
Jul 23, 1998
From: CASTELHANO, ARLINDO; WITTER, DAVID J.
To: CADUS PHARMACEUTICAL CORPORATION
Reel/Frame 009636/0077 →
Assignment of Assignor's Interest
Aug 3, 1999
From: CADUS PHARMACEUTICAL CORPORATION, A CORPORATION OF DELAWARE
To: OSI PHARMACEUTICALS, INC., A CORPORATION OF DELAWARE
Reel/Frame 010137/0959 →
Merger and Change of Name
Aug 30, 1999
From: ONCOGENE SCIENCE, INC.
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 010197/0519 →
Assignment of Assignor's Interest
Nov 4, 2002
From: IWATA, KENNETH K.; STEPHENSON, JOHN R.; GOLD, LESLIE I
To: ONCOGENE SCIENCE, INC.
Reel/Frame 013469/0930 →